Talking Points and FAQs: Safety of Pfizer's Bivalent Booster (English, Spanish)

Talking points and FAQs explain concerns that have been circulating in January 2023 about a potential link between Pfizer’s bivalent booster and an increased risk of stroke in older adults. The talking points address these concerns by noting that the CDC and FDA have not found a link to stroke after further investigation. Bivalent boosters remain critical for older adults. A related graphic is available here: Social Media: Graphic Promotes the Safety of Updated COVID-19 Boosters (English, Spanish).